These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1967902)

  • 61. Population-based genetic carrier screening for cystic fibrosis in Victoria.
    Archibald AD; Massie J; Smith MJ; Dalton DG; du Sart D; Amor DJ
    Med J Aust; 2014 Mar; 200(4):205-6. PubMed ID: 24580517
    [No Abstract]   [Full Text] [Related]  

  • 62. Carrier screening for cystic fibrosis.
    Beaudet AL
    Am J Hum Genet; 1990 Oct; 47(4):603-5. PubMed ID: 2220802
    [No Abstract]   [Full Text] [Related]  

  • 63. Cystic fibrosis: prospects for screening and therapy.
    Lancet; 1990 Jan; 335(8681):79-80. PubMed ID: 1688641
    [No Abstract]   [Full Text] [Related]  

  • 64. Frequency of the delta F508 and exon 11 mutations in Norwegian cystic fibrosis patients.
    Eiklid K; Tranebjaerg L; Eiken HG; Pedersen JC; Michalsen H; Fluge G; Schwartz M; Nilsen BR; Bolle R; Skyberg D
    Clin Genet; 1993 Jul; 44(1):12-4. PubMed ID: 7691448
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Screening and the new genetics.
    Cooper JD; Franks AJ
    J Public Health Med; 1997 Mar; 19(1):121. PubMed ID: 9138228
    [No Abstract]   [Full Text] [Related]  

  • 66. Approaches for cystic fibrosis diagnosis.
    Findlay I
    Hum Reprod; 1997 Nov; 12(11 Suppl):166-9. PubMed ID: 9433974
    [No Abstract]   [Full Text] [Related]  

  • 67. Implementing carrier screening for cystic fibrosis outside the clinic: ethical analysis in the light of the personalist view.
    Di Pietro ML; Teleman AA; Gonzalez-Melado FJ; Zace D; Di Raimo FR; Lucidi V; Refolo P
    Clin Ter; 2018; 169(2):e71-e76. PubMed ID: 29595869
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Three additional DNA polymorphisms in the met gene and D7S8 locus: use in prenatal diagnosis of cystic fibrosis.
    Dean M; O'Connell P; Leppert M; Park M; Amos JA; Phillips DG; White R; Vande Woude GF
    J Pediatr; 1987 Oct; 111(4):490-5. PubMed ID: 2888841
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Willingness to pay for antenatal carrier screening for cystic fibrosis.
    Donaldson C; Shackley P; Abdalla M; Miedzybrodzka Z
    Health Econ; 1995; 4(6):439-52. PubMed ID: 8653184
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
    Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
    Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Progress in the analysis of cystic fibrosis: prenatal diagnosis and carrier detection].
    Estivill X
    Med Clin (Barc); 1989 Mar; 92(10):375-7. PubMed ID: 2565992
    [No Abstract]   [Full Text] [Related]  

  • 72. Genetic screening for reproductive planning: methodological and conceptual issues in policy analysis.
    Asch DA; Hershey JC; Pauly MV; Patton JP; Jedrziewski MK; Mennuti MT
    Am J Public Health; 1996 May; 86(5):684-90. PubMed ID: 8629720
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic advances in cystic fibrosis: to screen, to treat or both?
    Super M; Abbott J
    Disabil Rehabil; 1998; 20(6-7):202-8. PubMed ID: 9637928
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mass screening for cystic fibrosis heterozygotes: two assay systems compared.
    Gilfillan A; Axton R; Brock DJ
    Clin Chem; 1994 Feb; 40(2):197-9. PubMed ID: 8313593
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cystic fibrosis carrier testing in early pregnancy by general practitioners.
    Harris H; Scotcher D; Hartley N; Wallace A; Craufurd D; Harris R
    BMJ; 1993 Jun; 306(6892):1580-3. PubMed ID: 8329921
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Decision analysis for medical managers.
    Thornton JG; Lilford RJ
    BMJ; 1995 Mar; 310(6982):791-4. PubMed ID: 7711587
    [No Abstract]   [Full Text] [Related]  

  • 77. Carrier screening for cystic fibrosis: implications for obstetric and gynecologic practice.
    Elias S; Annas GJ; Simpson JL
    Am J Obstet Gynecol; 1991 Apr; 164(4):1077-83. PubMed ID: 2014829
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cystic fibrosis screening: research alternatives needed.
    Lieberman J
    Lancet; 1990 May; 335(8700):1284. PubMed ID: 1971356
    [No Abstract]   [Full Text] [Related]  

  • 79. Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.
    Massie J; Petrou V; Forbes R; Curnow L; Ioannou L; Dusart D; Bankier A; Delatycki M
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):484-9. PubMed ID: 19780730
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Informativity of intragenic microsatellites for carrier detection and prenatal diagnosis of cystic fibrosis in the Italian population.
    Magnani C; Cremonesi L; Belloni E; Ferrari M; Seia M; Russo MP; Devoto M; Ronchetto P; Romeo G
    Clin Genet; 1994 Mar; 45(3):135-9. PubMed ID: 7913006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.